Amy Shurtleff, , works in a biosafety level 4 laboratory at USAMRIID. Shurtleff is part of a team that evaluated the protective efficacy of Merck's EBOV vaccine, V920.


Size: 1155px × 1732px
Photo credit: © PR Collection / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: &, -cb, africa, agency, agency’, air, america, archive, armed, army, biological, biology, bravery, cb, cbdp, chem/bio, chemical, civilians, combating, commitment, countering, courage, cwmd, dedicatio, dedication, defen, defence, defense, destruction, development, diseases, displaying, dtra, ebola, employee, executive, federal, force, forces, government, infectious, institute, joint, jpeo, jpeo-cbd, jsto, mass, medical, merck, military, navy, office, outbreak, program, reduction, reportage, research, sacrifice, science, service, serviceman, servicemen, states, synbio, synthetic, tech, technology, threat, united, usa, usamriid, v920, weapons, west